Drugs with this side effect
- 5-ASA: postmarketing, 0% - 3%
- 5-azacytidine: common, 0.98% - 6.29%
- Benicar-HCT
- Bivalirudin: postmarketing
- CGP 19835A: common
- Cancidas: 0% - 4%
- D-penicillamine
- Enfuvirtide: 1.9% - 2.2%
- Eptifibatide: 0.0962% - 1.35%
- FAMP
- FK463: 0% - 23.3%
- Fe(III
- Glat copolymer: frequent
- Goserelin: 1.28% - 12%
- K779
- L-Dmp: infrequent
- LMWH: 0% - 2%
- Leuprorelin: 4% - 6%
- Lisinopril
- Lutalyse
- MDV3100: 1.8% - 6.9%
- Octreotide
- PGE1: 1% - 10%
- Refludan: 0% - 6.6%
- Revasc
- UDCA
- VACV
- abiraterone: 0.6% - 1.3%
- acamprosate: rare
- acetate
- acetazolamide
- acitretin: postmarketing
- acyclovir
- adefovir dipivoxil: 11%
- allopurinol: postmarketing
- alpha-methyl-p-tyrosine
- amphotericin B: 14%
- amsacrine
- anagrelide: 2%
- apixaban: uncommon, common, 1.43% - 2.1%
- argatroban: 0.5% - 11.6%
- arginine: postmarketing
- aripiprazole
- atazanavir: uncommon
- atorvastatin
- auranofin
- avanafil
- axitinib: 3% - 3.6%
- azelastine
- baclofen: rare
- benzathine penicillin
- bexarotene: 10%
- bicalutamide: 7% - 12%
- bleomycin hydrochloride
- bortezomib
- bosentan
- bromcresol green: 2% - 38%
- budesonide
- bupivacaine: 1.1% - 1.96%
- busulfan
- cabazitaxel: 1% - 2%
- cabozantinib
- candesartan
- candesartan cilexetil
- capecitabine
- carbamazepine: very rare
- carvedilol: 2.9%
- cefaclor
- cefditoren
- cefpodoxime
- ceftriaxone
- celecoxib
- cephem
- cetirizine
- cevimeline
- chlorhexidine gluconate
- cidofovir
- cilostazol
- ciprofloxacin: postmarketing, rare, 1.2%
- citalopram: rare, infrequent
- clarithromycin
- clofarabine: common
- clomipramine: infrequent
- clopidogrel: very rare, postmarketing
- cobicistat: uncommon
- colchicine
- colestyramine
- conivaptan: 1.6%
- copolymer 1
- cyclophosphamide: postmarketing
- cyproterone acetate
- dabigatran etexilate: uncommon
- dabrafenib
- dalteparin: 0% - 1.15%
- danazol
- dantrolene
- darunavir
- dasatinib
- delamanid
- delavirdine
- deprenyl: infrequent
- diatrizoate
- diazoxide
- diclofenac: very rare, 0% - 2%
- dicloxacillin: uncommon
- diflunisal
- dolasetron
- donepezil: infrequent, frequent
- doxazosin: postmarketing, 1% - 1.8%
- doxorubicin
- efavirenz: 1% - 4%
- emtricitabine: 2% - 3%
- entacapone
- entecavir: 6% - 10%
- eplerenone
- eprosartan
- ergonovine
- eribulin
- ertapenem
- esomeprazole magnesium
- estazolam: rare
- estradiol
- ethacrynic acid
- ethosuximide
- etodolac: postmarketing
- etoricoxib
- everolimus
- famotidine
- febuxostat
- felbamate
- fenoprofen
- fentanyl
- flecainide
- flucloxacillin
- fludarabine: 2% - 3%
- fluoxetine: infrequent
- flurbiprofen
- flutamide: 7% - 12%
- fluvoxamine: rare, infrequent
- fondaparinux: uncommon, common
- formoterol
- foscarnet
- fosfomycin
- fosfomycin trometamol
- gabapentin: infrequent
- gadobenate dimeglumine
- gadofosveset
- gadoversetamide
- galantamine: infrequent, 3%
- ganciclovir
- gatifloxacin
- gefitinib: 0% - 6%
- gemcitabine: postmarketing, very common, 0% - 35%
- gemifloxacin: postmarketing
- gold sodium thiomalate
- hexaminolevulinate
- hydralazine: uncommon
- hydroxybutyrate: frequent
- ibuprofen: 1%
- ifosfamide: 46% - 6-92%
- imatinib: infrequent, uncommon
- indinavir
- indomethacin
- insulin detemir
- iodixanol
- iopamidol
- iopromide: postmarketing
- ioversol
- ioxilan
- isosorbide-5-mononitrate
- itraconazole
- ivermectin
- ketoprofen
- ketorolac: postmarketing
- ketorolac tromethamine: postmarketing
- lamotrigine: infrequent
- lansoprazole: postmarketing
- leflunomide
- lenalidomide: postmarketing
- lomefloxacin
- lomitapide
- mefenamic acid
- melatonin
- meloxicam: 0% - 1.3%
- memantine: infrequent
- mesna: 5.9% - 8%
- methazolamide
- methotrexate
- methylergometrine
- methylphenidate
- milnacipran
- mirtazapine: infrequent
- misoprostol: postmarketing
- mitotane
- mitoxantrone: 11%
- modafinil
- moxifloxacin
- mycophenolate mofetil: 11.3% - 14%
- mycophenolic acid
- nabumetone: postmarketing, 0.4%
- nafcillin
- naproxen: postmarketing
- nefazodone: infrequent
- nicardipine: 0.7%
- nifedipine
- nilotinib: uncommon
- nilutamide
- nisoldipine
- norfloxacin: postmarketing
- ofloxacin: postmarketing
- olanzapine: infrequent
- olmesartan: common, 1.52% - 2.65%
- olmesartan medoxomil
- olsalazine
- omeprazole: postmarketing
- oxacillin
- oxaliplatin: 0% - 4%
- oxaprozin
- oxcarbazepine
- oxybutynin
- oxycodone
- paclitaxel
- pamidronate: very rare, postmarketing
- pantoprazole: postmarketing
- paroxetine: rare, infrequent
- pazopanib
- penicillin
- pentamidine
- pentosan polysulfate
- pergolide: frequent, 1.1%
- perindopril
- perindopril erbumine
- pilocarpine
- pioglitazone
- piroxicam
- pixantrone
- podophyllotoxin
- posaconazole
- pramipexole
- prasugrel
- pregabalin: infrequent
- probenecid
- procarbazine
- propafenone: 1.59% - 2.94%
- prostacyclin
- pyrimethamine
- rabeprazole: rare
- ranolazine
- rapamycin: 13%
- rasagiline: frequent
- remifentanil: 0% - 2.44%
- retigabine: 1% - 2%
- retinoic acid: postmarketing
- rifampicin
- rifapentine
- rifaximin
- riluzole: infrequent, uncommon
- risperidone: infrequent
- ritonavir
- rivaroxaban
- rivastigmine: infrequent, frequent
- ropinirole: infrequent
- ropivacaine: 0.9% - 4.6%
- rosuvastatin
- rufinamide: infrequent
- ruxolitinib: very common, 2.3% - 13.3%
- salbutamol
- salmon calcitonin acetate
- samarium: 5.03%
- sertraline: postmarketing, rare
- sibutramine
- sildenafil: postmarketing, uncommon
- sitaxsentan: 0.913%
- sparfloxacin
- stavudine
- sulfasalazine
- sulindac
- sumatriptan: rare
- tacrolimus
- tadalafil
- telavancin: uncommon
- telmisartan
- temsirolimus
- tenofovir: 2%
- tenofovir disoproxil fumarate: 2% - 3%
- testosterone: postmarketing, uncommon
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- thalidomide: 0% - 11.1%
- theophylline
- thiabendazole
- thiazide
- thiotepa
- tiagabine: infrequent
- tiaprofenic acid
- ticagrelor
- ticlopidine
- tiopronin
- tizanidine: rare
- tolcapone: infrequent
- tolmetin
- topiramate: 0% - 2%
- tramadol: postmarketing, uncommon
- trametinib
- trazodone
- treprostinil: 0.847%
- trimethoprim: very rare
- trospium chloride
- v 1784: postmarketing
- valdecoxib
- valganciclovir: 4.27% - 6.41%
- valrubicin
- vandetanib
- vardenafil
- venlafaxine: infrequent
- vinflunine
- voriconazole: common
- warfarin
- zaleplon: infrequent
- zidovudine
- ziprasidone: infrequent
- zoledronic acid: postmarketing, uncommon
- zolmitriptan: infrequent
- zonisamide: infrequent
- zopiclone: infrequent
|
Drugs with this indication
|
